Conduit Pharmaceuticals Ownership 2024 | Who Owns Conduit Pharmaceuticals Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.30%

Insider Ownership

25.63%

Retail Ownership

74.07%

Institutional Holders

1.00

Conduit Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
COWEN AND COMPANY, LLC	-	-	-	-16,200	-100.00%	-	Sep 30, 2023
AQR ARBITRAGE LLC	-	-	-	-73,960	-100.00%	-	Sep 30, 2023
WOLVERINE ASSET MANAGEMENT LLC	-	-	-	-133,136	-100.00%	-	Sep 30, 2023
WALLEYE TRADING LLC	-	-	-	-71,640	-100.00%	-	Sep 30, 2023
DLD ASSET MANAGEMENT, LP	-	-	-	-55,726	-100.00%	-	Sep 30, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	-	-	-	-144,998	-100.00%	-	Sep 30, 2023
PERISCOPE CAPITAL INC.	-	-	-	-100,000	-100.00%	-	Sep 30, 2023
CLEAR STREET LLC	-	-	-	-1,797	-100.00%	-	Sep 30, 2023
SHAOLIN CAPITAL MANAGEMENT LLC	-	-	-	-517,444	-100.00%	-	Sep 30, 2023
SKYVIEW INVESTMENT ADVISORS, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
KIM, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
CRYSTALLINE MANAGEMENT INC.	-	-	-	-231,661	-100.00%	-	Sep 30, 2023
SEA OTTER ADVISORS LLC	-	-	-	-42,432	-100.00%	-	Sep 30, 2023

Conduit Pharmaceuticals's largest institutional shareholder is COWEN AND COMPANY, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
COWEN AND COMPANY, LLC	-	-	-	-16,200	-100.00%	-	Sep 30, 2023
AQR ARBITRAGE LLC	-	-	-	-73,960	-100.00%	-	Sep 30, 2023
WOLVERINE ASSET MANAGEMENT LLC	-	-	-	-133,136	-100.00%	-	Sep 30, 2023
WALLEYE TRADING LLC	-	-	-	-71,640	-100.00%	-	Sep 30, 2023
DLD ASSET MANAGEMENT, LP	-	-	-	-55,726	-100.00%	-	Sep 30, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	-	-	-	-144,998	-100.00%	-	Sep 30, 2023
PERISCOPE CAPITAL INC.	-	-	-	-100,000	-100.00%	-	Sep 30, 2023
CLEAR STREET LLC	-	-	-	-1,797	-100.00%	-	Sep 30, 2023
SHAOLIN CAPITAL MANAGEMENT LLC	-	-	-	-517,444	-100.00%	-	Sep 30, 2023
SKYVIEW INVESTMENT ADVISORS, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
KIM, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
CRYSTALLINE MANAGEMENT INC.	-	-	-	-231,661	-100.00%	-	Sep 30, 2023
SEA OTTER ADVISORS LLC	-	-	-	-42,432	-100.00%	-	Sep 30, 2023

The largest Conduit Pharmaceuticals shareholder by % of total assets is COWEN AND COMPANY, LLC. The company owns 0.00 shares of Conduit Pharmaceuticals (MURF), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CLEAR STREET LLC	-	-	-	-1,797	-100.00%	-	Sep 30, 2023
COWEN AND COMPANY, LLC	-	-	-	-16,200	-100.00%	-	Sep 30, 2023
SEA OTTER ADVISORS LLC	-	-	-	-42,432	-100.00%	-	Sep 30, 2023
DLD ASSET MANAGEMENT, LP	-	-	-	-55,726	-100.00%	-	Sep 30, 2023
WALLEYE TRADING LLC	-	-	-	-71,640	-100.00%	-	Sep 30, 2023
AQR ARBITRAGE LLC	-	-	-	-73,960	-100.00%	-	Sep 30, 2023
PERISCOPE CAPITAL INC.	-	-	-	-100,000	-100.00%	-	Sep 30, 2023
WOLVERINE ASSET MANAGEMENT LLC	-	-	-	-133,136	-100.00%	-	Sep 30, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	-	-	-	-144,998	-100.00%	-	Sep 30, 2023
KIM, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
SKYVIEW INVESTMENT ADVISORS, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
CRYSTALLINE MANAGEMENT INC.	-	-	-	-231,661	-100.00%	-	Sep 30, 2023
SHAOLIN CAPITAL MANAGEMENT LLC	-	-	-	-517,444	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Conduit Pharmaceuticals's largest institutional buyer is CLEAR STREET LLC. The company purchased -1.80K stocks of MURF, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SHAOLIN CAPITAL MANAGEMENT LLC	-	-	-	-517,444	-100.00%	-	Sep 30, 2023
CRYSTALLINE MANAGEMENT INC.	-	-	-	-231,661	-100.00%	-	Sep 30, 2023
SKYVIEW INVESTMENT ADVISORS, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
KIM, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	-	-	-	-144,998	-100.00%	-	Sep 30, 2023
WOLVERINE ASSET MANAGEMENT LLC	-	-	-	-133,136	-100.00%	-	Sep 30, 2023
PERISCOPE CAPITAL INC.	-	-	-	-100,000	-100.00%	-	Sep 30, 2023
AQR ARBITRAGE LLC	-	-	-	-73,960	-100.00%	-	Sep 30, 2023
WALLEYE TRADING LLC	-	-	-	-71,640	-100.00%	-	Sep 30, 2023
DLD ASSET MANAGEMENT, LP	-	-	-	-55,726	-100.00%	-	Sep 30, 2023
SEA OTTER ADVISORS LLC	-	-	-	-42,432	-100.00%	-	Sep 30, 2023
COWEN AND COMPANY, LLC	-	-	-	-16,200	-100.00%	-	Sep 30, 2023
CLEAR STREET LLC	-	-	-	-1,797	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Conduit Pharmaceuticals's biggest institutional seller is SHAOLIN CAPITAL MANAGEMENT LLC. The company sold -0.52M shares of MURF, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SHAOLIN CAPITAL MANAGEMENT LLC	-	-	-	-517,444	-100.00%	-	Sep 30, 2023
CRYSTALLINE MANAGEMENT INC.	-	-	-	-231,661	-100.00%	-	Sep 30, 2023
SKYVIEW INVESTMENT ADVISORS, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
KIM, LLC	-	-	-	-150,000	-100.00%	-	Sep 30, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	-	-	-	-144,998	-100.00%	-	Sep 30, 2023
WOLVERINE ASSET MANAGEMENT LLC	-	-	-	-133,136	-100.00%	-	Sep 30, 2023
PERISCOPE CAPITAL INC.	-	-	-	-100,000	-100.00%	-	Sep 30, 2023
AQR ARBITRAGE LLC	-	-	-	-73,960	-100.00%	-	Sep 30, 2023
WALLEYE TRADING LLC	-	-	-	-71,640	-100.00%	-	Sep 30, 2023
DLD ASSET MANAGEMENT, LP	-	-	-	-55,726	-100.00%	-	Sep 30, 2023
SEA OTTER ADVISORS LLC	-	-	-	-42,432	-100.00%	-	Sep 30, 2023
COWEN AND COMPANY, LLC	-	-	-	-16,200	-100.00%	-	Sep 30, 2023
CLEAR STREET LLC	-	-	-	-1,797	-100.00%	-	Sep 30, 2023

Conduit Pharmaceuticals's largest sold out institutional shareholder by shares sold is SHAOLIN CAPITAL MANAGEMENT LLC, sold -0.52M shares, valued at -, as of undefined.

Conduit Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
SPECIAL OPPORTUNITIES FUND, INC.	0.22%	94,500	-	-	Mar 31, 2024
Saba Capital Income & Opportunities Fund	0.02%	51,468	-	-	Jan 31, 2024
Investment Managers Series Trust II	0.01%	94,583	-	-	Jan 31, 2024
Franklin Alternative Strategies Funds	0.00%	32,534	-	-	Feb 29, 2024

Conduit Pharmaceuticals's largest mutual fund holder by % of total assets is "SPECIAL OPPORTUNITIES FUND, INC.", owning 94.50K shares, compromising 0.22% of its total assets.

Conduit Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 23	1	-94.12%
30 Jun, 23	17	-
31 Mar, 23	17	-55.26%
31 Dec, 22	38	40.74%
30 Sep, 22	27	12.50%
30 Jun, 22	24	700.00%
31 Mar, 22	3	-

As of 30 Sep 23, 1 institutions are holding Conduit Pharmaceuticals's shares, representing a decrease of -94.12% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 23	198,925	-87.42%
30 Jun, 23	1,581,480	-25.30%
31 Mar, 23	2,117,044	-80.74%
31 Dec, 22	10,992,632	3.97%
30 Sep, 22	10,573,330	9.88%
30 Jun, 22	9,622,560	807.61%
31 Mar, 22	1,060,206	-

Conduit Pharmaceuticals (MURF) has 198.93K shares outstanding as of 30 Sep 23, down -87.42% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 23	0.30%	5.26%
30 Jun, 23	2.39%	23.33%
31 Mar, 23	3.20%	1.16%
31 Dec, 22	16.62%	6.50%
30 Sep, 22	15.99%	7.55%
30 Jun, 22	14.55%	566.12%
31 Mar, 22	1.60%	-

As of 30 Sep 23, Conduit Pharmaceuticals is held by 0.30% institutional shareholders, representing a 5.26% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 23	-	-100.00%
30 Jun, 23	5	-37.50%
31 Mar, 23	8	-50.00%
31 Dec, 22	16	60.00%
30 Sep, 22	10	-58.33%
30 Jun, 22	24	700.00%
31 Mar, 22	3	-

- institutional shareholders have increased their position in MURF stock as of 30 Sep 23 compared to 5 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 23	1	-80.00%
30 Jun, 23	5	-44.44%
31 Mar, 23	9	125.00%
31 Dec, 22	4	300.00%
30 Sep, 22	1	-
30 Jun, 22	-	-
31 Mar, 22	-	-

1 institutional shareholders have reduced their position in MURF stock as of 30 Sep 23 compared to 5 in the previous quarter (a -80.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 23	1	-94.12%	198,925	-87.42%	0.30%	5.26%	-	-100.00%	1	-80.00%
30 Jun, 23	17	-	1,581,480	-25.30%	2.39%	23.33%	5	-37.50%	5	-44.44%
31 Mar, 23	17	-55.26%	2,117,044	-80.74%	3.20%	1.16%	8	-50.00%	9	125.00%
31 Dec, 22	38	40.74%	10,992,632	3.97%	16.62%	6.50%	16	60.00%	4	300.00%
30 Sep, 22	27	12.50%	10,573,330	9.88%	15.99%	7.55%	10	-58.33%	1	-
30 Jun, 22	24	700.00%	9,622,560	807.61%	14.55%	566.12%	24	700.00%	-	-
31 Mar, 22	3	-	1,060,206	-	1.60%	-	3	-	-	-

Conduit Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Sep 26, 2023	Regan Andrew	director, 10 percent owner			Sell	-	-	-	66,650
Sep 26, 2023	Tapolczay David	director, officer	Chief Executive Officer		Sell	-	-	-	2,003,324
Sep 26, 2023	Heilbron Jack Kendrick		-	J-Other	Sell	45,000	-	-	4,015,250

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 14, 2023	Lewis-Hall Freda C	director	-	A-Award	Buy	65,000	$5.51	$358.15K	65,000
Dec 05, 2023	Bligh James	director	-	A-Award	Buy	223,634	$5.51	$1.23M	223,634
Dec 05, 2023	Farley Chele Chiavacci	director	-	A-Award	Buy	65,000	$5.51	$358.15K	65,000
Dec 05, 2023	McNealey Jennifer Isacoff	director	-	A-Award	Buy	65,000	$5.51	$358.15K	65,000
Dec 05, 2023	Charles Faith L.	director	-	A-Award	Buy	65,000	$5.51	$358.15K	65,000
Dec 05, 2023	Tapolczay David	director	-	A-Award	Buy	298,179	$5.51	$1.64M	298,179
Dec 05, 2023	Sragovicz Adam	officer	Chief Financial Officer	A-Award	Buy	74,545	-	-	74,545
Sep 26, 2023	Farley Chele Chiavacci	director	-	A-Award	Buy	15,000	-	-	15,000
Sep 26, 2023	Farley Chele Chiavacci	director	-	A-Award	Buy	15,000	$11.50	$172.50K	15,000
Sep 26, 2023	McNealey Jennifer Isacoff	director			Buy	-	-	-	-
Sep 26, 2023	Bligh James	director			Buy	-	-	-	-
Sep 26, 2023	Lewis-Hall Freda C	director	-		Buy	-	-	-	2,003,324
Sep 26, 2023	Lewis-Hall Freda C	director	-		Buy	-	-	-	516,987
Sep 26, 2023	Regan Andrew	director, 10 percent owner			Buy	-	-	-	45,527,149
Sep 26, 2023	Regan Andrew	director, 10 percent owner			Sell	-	-	-	66,650
Sep 26, 2023	Tapolczay David	director, officer	Chief Executive Officer		Sell	-	-	-	2,003,324
Sep 26, 2023	Charles Faith L.	director			Buy	-	-	-	-
Sep 26, 2023	Heilbron Jack Kendrick		-	M-Exempt	Buy	4,060,250	-	-	4,060,250
Sep 26, 2023	Heilbron Jack Kendrick		-	J-Other	Sell	45,000	-	-	4,015,250
Sep 26, 2023	Heilbron Jack Kendrick		-	M-Exempt	Buy	754,000	$11.50	$8.67M	754,000

The last insider sell of Conduit Pharmaceuticals's stock was made by Regan Andrew on Sep 26 2023, selling - shares at - per share (valued at -).

Conduit Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	-	1	-

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Conduit Pharmaceuticals's insiders, as of Q1 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	-	-	-

As of Q1 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Conduit Pharmaceuticals's stocks.

Conduit Pharmaceuticals Peer Ownership

Ticker	Company
PNAC	Prime Number Acquisition I Corp.
MCAA	Mountain & Co. I Acquisition Corp.

MURF Ownership FAQ

Who Owns Conduit Pharmaceuticals?

Conduit Pharmaceuticals is owned by institutional shareholders (0.30%), insiders (25.63%), and public (74.07%). The largest institutional shareholder of Conduit Pharmaceuticals is COWEN AND COMPANY, LLC (0% of total shares) and the top mutual fund owner is SPECIAL OPPORTUNITIES FUND, INC. (0.22% of total shares).

Who are the major institutional shareholders of Conduit Pharmaceuticals?

Conduit Pharmaceuticals's major institutional shareholders are COWEN AND COMPANY, LLC, AQR ARBITRAGE LLC, WOLVERINE ASSET MANAGEMENT LLC, WALLEYE TRADING LLC, and DLD ASSET MANAGEMENT, LP. The top five shareholders own together 0% of the company's share outstanding.

How many Conduit Pharmaceuticals shareholders are there?

As of Sep 2023, there are 1 institutional shareholders of Conduit Pharmaceuticals.

What percentage of Conduit Pharmaceuticals is owned by COWEN AND COMPANY, LLC?

COWEN AND COMPANY, LLC owns 0 shares of Conduit Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).

What percentage of Conduit Pharmaceuticals is owned by AQR ARBITRAGE LLC?

As of Sep 2023, AQR ARBITRAGE LLC holds 0 shares of Conduit Pharmaceuticals (MURF), compromising 0% of the company, valued at $0.

What percentage of Conduit Pharmaceuticals is owned by WOLVERINE ASSET MANAGEMENT LLC?

WOLVERINE ASSET MANAGEMENT LLC is the third largest holder of Conduit Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).